These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7870369)

  • 41. Cyclosporine pharmacokinetics in a renal allograft recipient.
    Chander G; Abraham G; V R J; Soundarajan P
    Indian Pediatr; 2001 Aug; 38(8):911-4. PubMed ID: 11521005
    [No Abstract]   [Full Text] [Related]  

  • 42. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 43. Improvement in anaemia following renal transplantation but not after erythropoietin therapy in a patient with sickle-cell disease.
    Thuraisingham RC; Roger SD; Macdougall IC; Cavill I; Stephens AD; Baker LR; Raine AE
    Nephrol Dial Transplant; 1993; 8(4):371-2. PubMed ID: 8390015
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat.
    Paul LC; Chea R; Davidoff A; Benediktsson H
    Transplant Proc; 1994 Oct; 26(5):2567-8. PubMed ID: 7940793
    [No Abstract]   [Full Text] [Related]  

  • 45. Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes.
    Citterio F; Serino F; Pozzetto U; Fioravanti P; Caizzi P; Castagneto M
    Transplant Proc; 1996 Aug; 28(4):2174-6. PubMed ID: 8769192
    [No Abstract]   [Full Text] [Related]  

  • 46. Recombinant erythropoietin: does it really effect sensitization?
    Phelan DL; Hibbett S; Wetter L; Hanto DW; Mohanakumar T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):409-10. PubMed ID: 1990569
    [No Abstract]   [Full Text] [Related]  

  • 47. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A life with kidney failure, transplantation and dialysis. "Then there is no more fear"].
    Verworner H
    Osterr Krankenpflegez; 1999 Dec; 52(12):18-20. PubMed ID: 10788906
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
    Acharya VN; Sinha DK; Almeida AF; Pathare AV
    J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful use of recombinant human erythropoietin in pregnancy.
    McGregor E; Stewart G; Junor BJ; Rodger RS
    Nephrol Dial Transplant; 1991; 6(4):292-3. PubMed ID: 1881584
    [No Abstract]   [Full Text] [Related]  

  • 53. Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study.
    Gomez-Alamillo C; Fernández-Fresnedo G; Ortega F; Campistol JM; Gentil MA; Arias M;
    Transplant Proc; 2010 Oct; 42(8):2935-7. PubMed ID: 20970575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance to recombinant human erythropoietin therapy in a child with renal failure due to primary hyperoxaluria type 1.
    Lavoratti GC; Seracini D; Pela I; Materassi M; Vichi GF; Di Lollo S; Bartolozzi G
    Nephrol Dial Transplant; 1994; 9(11):1645-8. PubMed ID: 7870357
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of chronic renal failure anemia by recombinant erythropoietin and polycythemia following kidney transplantation.
    Kessler M; Legrand E; Mertes M; Renoult E; Hestin D
    Nephron; 1992; 62(3):370-1. PubMed ID: 1436359
    [No Abstract]   [Full Text] [Related]  

  • 56. Biotechnology--the enormous cost of success.
    Doolittle RF
    N Engl J Med; 1991 May; 324(19):1360-2. PubMed ID: 2017234
    [No Abstract]   [Full Text] [Related]  

  • 57. Recombinant human erythropoietin and renal transplantation. The Canadian Erythropoietin Study Group.
    Keown PA
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):52-8. PubMed ID: 2192417
    [No Abstract]   [Full Text] [Related]  

  • 58. Towards long-term graft survival in renal transplantation: the role of erythropoietin.
    Moore R
    Nephrol Dial Transplant; 1995; 10 Suppl 1():20-2. PubMed ID: 7617275
    [No Abstract]   [Full Text] [Related]  

  • 59. Nursing care study - renal failure. A father's kidney for two.
    Winder L; Donovan M
    Nurs Mirror; 1980 Jan; 150(1):37-9. PubMed ID: 6985730
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of recombinant human erythropoietin on the anemia of renal transplant recipients with chronic rejection.
    Yoshimura N; Oka T; Ohmori Y; Aikawa I
    Transplantation; 1989 Sep; 48(3):527-9. PubMed ID: 2675414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.